Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hematopoietic stem cell transplantation
Phenotype C0024299|lymphoma
Sentences 10
PubMedID- 24314990 Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
PubMedID- 24025414 Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.
PubMedID- 22641292 Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large b-cell lymphoma associated with follicular lymphoma, or de novo diffuse large b-cell lymphoma.
PubMedID- 24759022 [clinical analysis of 81 cases of malignant lymphoma treated with autologous hematopoietic stem cell transplantation].
PubMedID- 24198512 Although much has been published on the application of autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma (fl), no uniform consensus exists among physicians on when to use this strategy.
PubMedID- 19892025 The additional use of viral entry inhibitors during autologous hematopoietic stem cell transplantation in patients with non-hodgkin lymphoma and hiv-1 infection.
PubMedID- 22089346 In the peripheral blood or bone marrow of 4 hematopoietic stem cell transplantation patients with leukemia or lymphoma, we identified tumor dna on the basis of str loci showing copy number alteration.
PubMedID- 25702654 High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-hodgkin's lymphoma in the rituximab era.
PubMedID- 21234094 Allogeneic hematopoietic stem cell transplantation, with the putative graft-versus-lymphoma effect, offers a potentially curative option in patients with advanced disease.
PubMedID- 23813647 Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the ebmt-lymphoma working party.

Page: 1